EFTA-India Free Trade Agreement and Patents Rules Amendment: Compromising Public Accountability and Transparency in the Indian Patent System
SpicyIP
APRIL 7, 2024
She has been working in the field of access to medicines, patents and IP for more than a decade. She has been working on patent oppositions and was involved in patent challenges on key drugs including the Gleevec-Novartis case. Prathibha Sivasubramanian is a law researcher working with TWN.
Let's personalize your content